Dividend
Sequenom (Nasdaq: SQNM) 67.6% LOWER; announces delay in launch of SEQureDx Trisomy 21 test. Click here for the full report.
I-many, Inc. (Nasdaq: IMNY) 21.9% HIGHER; reports Q1 EPS of $0.02, 3 cents better than the analyst estimate of ($0.01). Revenue for the quarter was $9.9 million, versus the consensus of $8.5 million.
Green Mountain Coffee Roasters, Inc. (Nasdaq: GMCR) 19% HIGHER; reports Q1 EPS of $0.50, versus the analyst estimate of $0.36. Revenue for the quarter was $193.4 million, versus the consensus of $178.14 million. Sees FY09 EPS of $1.25-$1.35, versus the consensus of $1.31.
Skechers USA Inc. (NYSE: SKX) 18.8% HIGHER; reports Q1 EPS of $0.18, versus the analyst estimate of ($0.09). Revenue for the quarter was $343.5 million, versus the consensus of $333.03 million.
First Solar, Inc. (Nasdaq: FSLR) 15.7% HIGHER; reports Q1 EPS of $1.99, versus the analyst estimate of $1.51. Revenue ...
StreetInsider.com Morning Movers:
astrom Biosciences (Nasdaq: ASTM) 48% HIGHER; President Obama will lift the ban on federally funded human embryonic stem cell research.
StemCells Inc. (Nasdaq: STEM) 45% HIGHER; President Obama will lift the ban on federally funded human embryonic stem cell research.
Human Genome Sciences Inc. (Nasdaq: HGSI) 36% LOWER; Announces Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C
Geron Corporation (Nasdaq: GERN) 21% HIGHER; President Obama will lift the ban on federally funded human embryonic stem cell research.
Pluristem Therapeutics, Inc ...
StreetInsider.com Morning Movers:
Advanced Medical Optics Inc. (NYSE: EYE) 145% HIGHER; Abbott Labs (NYSE: ABT) announced a definitive agreement to acquire the company for $22 per share in cash, for a total transaction value of approximately $2.8 billion.
EXACT Sciences Corporation (NASDAQ: EXAS) 52% HIGHER; Sequenom, Inc. (NASDAQ: SQNM) submitted a proposal to the Board of Directors of EXACT Sciences Corporation (NASDAQ: EXAS) to acquire all of the outstanding shares of common stock of EXACT Sciences in an all-stock transaction valued at approximately $41 million. Under the terms of the proposal, each share of EXACT Sciences would be exchanged for $1.50 in Sequenom common stock ...
